Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study (Q79208787)
Jump to navigation
Jump to search
scientific article published on 05 October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study |
scientific article published on 05 October 2006 |
Statements
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study (English)
Carmen A Puliafito
Andrew A Moshfeghi
Philip J Rosenfeld
Stephan Michels
Erin N Marcus
Anna S Venkatraman
5 October 2006